These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 8355865
1. [Gabexate mesilate (FOY), a new synthetic protease inhibitor, in the treatment of shock. An Italian multicenter study]. Novelli GP, Innocenti P, Livi P. Minerva Anestesiol; 1993 May; 59(5):247-53. PubMed ID: 8355865 [Abstract] [Full Text] [Related]
3. [Gabexate mesilate in the treatment of acute pancreatitis. Results of a Hannover multicenter double-blind study with 50 patients]. Freise J, Melzer P, Schmidt FW, Horbach L. Z Gastroenterol; 1986 Apr; 24(4):200-11. PubMed ID: 3087076 [Abstract] [Full Text] [Related]
7. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction. Chen HM, Chen JC, Hwang TL, Jan YY, Chen MF. Hepatogastroenterology; 2000 Apr; 47(34):1147-50. PubMed ID: 11020900 [Abstract] [Full Text] [Related]
10. Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro. Lasson A, Balldin G, Ohlsson K. Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1409-15. PubMed ID: 6084637 [Abstract] [Full Text] [Related]
11. [Gabexate mesilate vs gabexate mesilate combined with octreotide in the prevention of postoperative complications of pancreatic surgery: preliminary results]. Bonora A, Bassi C, Falconi M, Sartori N, De Santis L, Dragonetti C, Innocenti P, Pederzoli P. Chir Ital; 2001 Dec; 53(1):65-72. PubMed ID: 11280830 [Abstract] [Full Text] [Related]
12. Does gabexate mesilate affect serum concentrations of acute phase proteins after endoscopic retrograde cholangiopancreatography examination? Pezzilli R, Gabbrielli A, Labate AM, D'Alessio P, Barakat B, Costamagna G, Dibenedetti F, Massa M, Merlini G, d'Eril GM. Hepatogastroenterology; 2003 Dec; 50(51):851-5. PubMed ID: 12828103 [Abstract] [Full Text] [Related]
14. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate]. Freise J. Fortschr Med; 1983 Aug 25; 101(31-32):1432-6. PubMed ID: 6194089 [Abstract] [Full Text] [Related]
16. Fatal cases of gabexate mesilate-induced anaphylaxis. Matsukawa Y, Nishinarita S, Sawada S, Horie T. Int J Clin Pharmacol Res; 2002 Aug 25; 22(3-4):81-3. PubMed ID: 12837044 [Abstract] [Full Text] [Related]
17. [Diagnosis and treatment of disseminated intravascular coagulation associated with neurosurgical diseases; a proposal of a new scoring system for DIC]. Kameyama S, Fujii Y, Koike T, Tanaka R, Takahashi H. No Shinkei Geka; 1992 Jul 25; 20(7):749-55. PubMed ID: 1630565 [Abstract] [Full Text] [Related]
18. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002). Bakker J, Grover R, McLuckie A, Holzapfel L, Andersson J, Lodato R, Watson D, Grossman S, Donaldson J, Takala J, Glaxo Wellcome International Septic Shock Study Group. Crit Care Med; 2004 Jan 25; 32(1):1-12. PubMed ID: 14707554 [Abstract] [Full Text] [Related]